| Filed On | Filing |
|---|---|
| 26 Oct 2011 |
8-K/A: Entry into a Material Definitive Agreement
On October 7, 2011, we entered into a Collaborative Development and License Agreement (the “Agreement”) with our affiliate VGX International (“VGX Int’l”). Under the Agreement, we and VGX Int’l will co-develop our SynCon® therapeutic vac... |
| 19 Nov 2009 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On November 17, 2009, Inovio’s Board (i) appointed Dr. Wells to be a member of the Audit Committee of the Board and the Nomination and Corporate Governance Committee of the Board, and (ii) appointed Mr. Williams to be a member of the Com... |
| 17 Aug 2009 |
8-K/A: Financial Statements and Exhibits
Unaudited Pro Forma Combined Balance Sheets as of March 31, 2009 |
| 16 Jun 2009 |
8-K/A: Financial Statements and Exhibits
The accompanying unaudited consolidated financial statements of VGX Pharmaceuticals, Inc. (VGX) have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information.... |
| 14 Mar 2008 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Employment Agreement (the “Agreement”) is made as of the 12th day of March, 2008, |
| 10 Sep 2007 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Employment Agreement (the “Agreement”) is made as of the 31 day of August, 2007, |
| 12 Apr 2005 |
8-K/A: Financial Statements and Exhibits
Effective January 25, 2005, Genetronics Biomedical Corporation (the "Company") consummated the acquisition (the "Acquisition") of Inovio AS, a Norwegian company, pursuant to a Stock Purchase Agreement by and among the Company, Inovio AS,... |
| 28 Mar 2002 |
8-K/A: Other Events
DR. AVTAR DHILLON recently joined our company as the President and Chief Executive Officer in September 2001 and a director in October 2001. Prior to joining our company, Dr. Dhillon was engaged by MDS Capital Corp. as a consultant in Ju... |
| 25 Mar 2002 |
8-K/A: Other Events
We consent to the incorporation by reference in the Registration Statement (Form S-8 Nos. 333-86377 and 333-58168) pertaining to the 1995 Stock Option Plan of Genetronics Biomedical Corporation (formerly Genetronics Biomedical Ltd.) and ... |
| 12 Mar 2002 |
8-K/A: Other Events
We consent to the incorporation by reference in the Registration Statement (Form S-8 Nos. 333-86377 and 333-58168) pertaining to the 1995 Stock Option Plan of Genetronics Biomedical Corporation (formerly Genetronics Biomedical Ltd.) and ... |
Loading...